Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes

D. R. Matthews; G. Fulcher; V. Perkovic; D. de Zeeuw; K. W. Mahaffey; J. Rosenstock; M. Davies; G. Capuano; M. Desai; W. Shaw; F. Vercruysse; G. Meininger; B. Neal

Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes

D. R. Matthews, G. Fulcher, V. Perkovic, D. de Zeeuw, K. W. Mahaffey, J. Rosenstock, M. Davies, G. Capuano, M. Desai, W. Shaw, F. Vercruysse, G. Meininger, B. Neal

Groningen Kidney Center (GKC)

Onderzoeksoutput: Meeting Abstract › Academic

Originele taal-2	English
Pagina's (van-tot)	S314-S315
Aantal pagina's	2
Tijdschrift	Diabetologia
Volume	55
Status	Published - okt.-2012

Handle.net

Permanente koppeling

Citeer dit

Matthews, D. R., Fulcher, G., Perkovic, V., de Zeeuw, D., Mahaffey, K. W., Rosenstock, J., Davies, M., Capuano, G., Desai, M., Shaw, W., Vercruysse, F., Meininger, G., & Neal, B. (2012). Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes. Diabetologia, 55, S314-S315.

@article{4d81329c637c47e68f53bd6e929d4652,

title = "Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes",

author = "Matthews, {D. R.} and G. Fulcher and V. Perkovic and {de Zeeuw}, D. and Mahaffey, {K. W.} and J. Rosenstock and M. Davies and G. Capuano and M. Desai and W. Shaw and F. Vercruysse and G. Meininger and B. Neal",

year = "2012",

month = oct,

language = "English",

volume = "55",

pages = "S314--S315",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

}

Matthews, DR, Fulcher, G, Perkovic, V, de Zeeuw, D, Mahaffey, KW, Rosenstock, J, Davies, M, Capuano, G, Desai, M, Shaw, W, Vercruysse, F, Meininger, G & Neal, B 2012, 'Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes', Diabetologia, vol. 55, blz. S314-S315.

TY - JOUR

T1 - Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes

AU - Matthews, D. R.

AU - Fulcher, G.

AU - Perkovic, V.

AU - de Zeeuw, D.

AU - Mahaffey, K. W.

AU - Rosenstock, J.

AU - Davies, M.

AU - Capuano, G.

AU - Desai, M.

AU - Shaw, W.

AU - Vercruysse, F.

AU - Meininger, G.

AU - Neal, B.

PY - 2012/10

Y1 - 2012/10

M3 - Meeting Abstract

SN - 0012-186X

VL - 55

SP - S314-S315

JO - Diabetologia

JF - Diabetologia

ER -